Forecast: (ALNY) for today April 24 & Weekly Forecast from 21 April to 27 April
Alnylam Pharmaceuticals icon

Forecast: (ALNY) for today April 24 & Weekly Forecast from 21 April to 27 April

Updated: April 24, 2024


Brief information about Alnylam Pharmaceuticals, Inc.

Ticker: ALNY

Sector: Healthcare

Closing price of the last trading day: $149.1

Last trading day: 03/11/2024

Analyst forecast price: $231.27

52-week high/low: $236.8 / $117.58

Shares of Alnylam Pharmaceuticals, Inc. are traded on the stock exchange under the ticker ALNY, marking their space in the competitive "Healthcare" sector. For stakeholders, tracking the dynamic price movement of ALNY is crucial for making informed investment decisions. In a market influenced by myriad factors, predicting the trajectory of these shares becomes both a challenge and a necessity. Predictive analytics and data-driven insights play a pivotal role in forecasting the performance of ALNY. The investors seeking up-to-date and accurate forecasts for Alnylam Pharmaceuticals, Inc. shares can turn to resources like Allforecast.com. The website stands out as a reliable tool offering real-time predictions, ensuring that investors are equipped with current and anticipated stock trends. On Allforecast.com, users gain access to a comprehensive analysis and predictions specifically tailored for ALNY, spanning varied timeframes - from the next day's anticipations to weekly, monthly, and yearly forecasts. The platform’s real-time updating mechanism ensures that the forecasted data aligns with the ongoing market trends and economic shifts, offering users actionable insights to optimize their investment strategies. The forecasts integrate a mix of qualitative and quantitative analyses, sector-specific trends within "Healthcare", and broader market dynamics to present a holistic view of ALNY's expected performance. By leveraging such precise and timely data, investors can strategize their moves, balancing risks and opportunities associated with Alnylam Pharmaceuticals, Inc.'s stocks. Navigating through the unpredictable terrains of the stock market requires actionable insights and timely data. Allforecast.com serves as a companion for investors eyeing ALNY, offering them a blend of accuracy and timeliness in predicting stock movements, aiding in informed and strategic investment choices.

Main Headquarters: Situated at 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US, this location serves as the primary hub for all corporate activities.

Alnylam Pharmaceuticals's Current Market Value: As of our last update, it's pegged at $26 075 865 000, indicating its standing in the financial landscape.

Shares Overview: Currently, 120 027 000 shares of Alnylam Pharmaceuticals are actively traded and held by the public.

Last year's EBITDA (Earnings Before Interest, Taxes, and Depreciation) for Alnylam Pharmaceuticals stood at -671 937 984$. This figure provides insights into the company's operational profitability. On the other hand, a negative EBITDA hints at Alnylam Pharmaceuticals's current challenges in achieving profitability.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for Alnylam Pharmaceuticals shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.



Alnylam Pharmaceuticals stock forecast

When considering an investment in Alnylam Pharmaceuticals, prospective investors often seek insights on its long-term performance. Our platform consolidates the expert analyses and projections from renowned global analysts to offer a unified consensus forecast for 2024, 2025, 2026, 2027, and 2028.

With these forecasts at your disposal, you can address critical questions like:

What will be the price of one share of Alnylam Pharmaceuticals in the subsequent years including 2024, 2025, 2026, 2027, and 2028?

What consensus have the analysts reached regarding the future performance of Alnylam Pharmaceuticals stock?

Is Alnylam Pharmaceuticals stock a viable option for both short-term and long-term investment?

Is it prudent to sell or hold Alnylam Pharmaceuticals shares in 2024?

Is 2024 the opportune moment to buy Alnylam Pharmaceuticals stock, or is patience a more viable strategy?

What are the anticipated entry and exit points for investing in Alnylam Pharmaceuticals stock, according to expert forecasts?

It’s pivotal to remember that these forecasts are to be utilized as informational resources and not definitive investment advice. The final investment decision rests solely upon the investor, contingent on their risk tolerance, investment goals, and thorough analysis of Alnylam Pharmaceuticals.

Insight into Our Forecasting Process

Our forecasting methodology encompasses the aggregation of public and expert data on Alnylam Pharmaceuticals, coupled with a sophisticated algorithm that calculates a weighted average forecast while eliminating outliers. This ensures that our audience receives a refined and realistic projection of Alnylam Pharmaceuticals stock’s future performance.

Alnylam Pharmaceuticals Daily Share Price Forecast for One Month

Our team has meticulously gathered and analyzed forecasts from a diverse pool of analysts to present a consolidated average daily forecast for Alnylam Pharmaceuticals shares over the upcoming month. It’s essential to bear in mind that short-term predictions can often be subject to significant volatility, influenced by a myriad of dynamic, real-time market factors.

As you scroll, you’ll discover a detailed graph illustrating the consensus forecast for Alnylam Pharmaceuticals stocks over the next 30 days. The gray spectrum of the chart delineates the historical trajectory of the stock’s price, while the turquoise spectrum provides a visual representation of the anticipated price, inclusive of potential fluctuation ranges, offering insights into prospective market trends and stock behaviors.

In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Alnylam Pharmaceuticals shares. Our integrated forecast predicts a peak price of $159.91 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 7.25% from the current standing.

On the flip side, the stock might plummet to a minimum of $148.69 within the same period. A decline of 0.28% signals caution, nudging investors towards a more conservative stance.

Consequently, a fluctuation corridor emerges, with the stock’s resistance at $159.91 and support at $148.69, indicating the oscillating nature of Alnylam Pharmaceuticals’s stock over the one-month spectrum. These oscillations, while providing trading opportunities, should be navigated with adept knowledge and strategic foresight.

So, what’s the trajectory of Alnylam Pharmaceuticals amidst these projections? The nuances of stock trading and investment are encapsulated in the constant ebb and flow of the market, influenced by intrinsic and extrinsic factors. Hence, a comprehensive, nuanced understanding of market dynamics, coupled with real-time analytics, emerges as the cornerstone for maximizing ROI and mitigating risks.

The evolution of Alnylam Pharmaceuticals’s stock is akin to a narrative unfolding, shaped by myriad factors including market trends, economic indicators, and investor sentiment. Each fluctuation is a chapter of this narrative, offering insights, challenges, and opportunities to the discerning investor.

Evaluating the resilience of the support level is crucial in gauging the future trajectory of Alnylam Pharmaceuticals shares. The anticipation is that the price will hover near the support level for 16 days. The support level at $148.69 appears to be resilient. A more pronounced fluctuation is anticipated, prompting a need for strategic reevaluation for investors.

It’s imperative to remember the innate unpredictability of the stock market. The actual future value of Alnylam Pharmaceuticals shares is subject to variables beyond predictive analytics. Nonetheless, investors can expect the stock to oscillate within the defined optimistic and pessimistic target price brackets, offering both challenges and opportunities for strategic trading and investment.

Forecast table for 30 days
Date Target Pes. Opt. Vol., %
Mar 27 155.37 153.14 156.98 2.51
Mar 28 156.62 155.19 158.53 2.15
Mar 29 154.38 152.09 156.55 2.93
Mar 30 154.42 153.25 155.98 1.78
Mar 31 156.02 152.94 156.84 2.55
Apr 01 154.08 151.59 154.88 2.17
Apr 02 153.80 152.40 155.44 1.99
Apr 03 153.48 150.96 154.63 2.43
Apr 04 151.16 148.69 154.07 3.62
Apr 05 151.71 149.46 154.59 3.43
Apr 06 153.21 151.98 154.77 1.84
Apr 07 154.29 152.88 156.81 2.57
Apr 08 155.93 153.74 158.32 2.98
Apr 09 155.77 154.03 156.62 1.68
Apr 10 155.28 154.07 157.22 2.04
Apr 11 155.85 153.54 158.85 3.46
Apr 12 153.90 153.10 154.82 1.12
Apr 13 153.46 152.07 156.46 2.89
Apr 14 153.42 151.47 155.82 2.87
Apr 15 151.11 149.81 152.80 1.99
Apr 16 152.76 150.73 154.23 2.32
Apr 17 150.85 149.44 152.66 2.15
Apr 18 154.07 151.35 155.91 3.02
Apr 19 155.83 153.00 157.21 2.75
Apr 20 157.21 154.14 159.91 3.74
Apr 21 157.37 155.57 158.23 1.71
Apr 22 153.36 150.85 156.19 3.54
Apr 23 154.48 152.63 157.33 3.08
Apr 24 156.21 154.66 158.32 2.36
Apr 25 152.35 151.00 154.21 2.12

Alnylam Pharmaceuticals Stock Forecast 27 Mar.

Presumably, on 03/27/2024, the price of shares will be in the range of $153.14 - $156.98. A $3.84 range width can provide 2.51% volatility. The weighted average price of this range is at $155.37, which is $2.62 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 28 Mar.

Presumably, on 03/28/2024, the price of shares will be in the range of $155.19 - $158.53. A $3.34 range width can provide 2.15% volatility. The weighted average price of this range is at $156.62, which is $1.25 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 29 Mar.

Presumably, on 03/29/2024, the price of shares will be in the range of $152.09 - $156.55. A $4.45 range width can provide 2.93% volatility. The weighted average price of this range is at $154.38, which is $2.24 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 30 Mar.

Presumably, on 03/30/2024, the price of shares will be in the range of $153.25 - $155.98. A $2.73 range width can provide 1.78% volatility. The weighted average price of this range is at $154.42, which is $0.04 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 31 Mar.

Presumably, on 03/31/2024, the price of shares will be in the range of $152.94 - $156.84. A $3.89 range width can provide 2.55% volatility. The weighted average price of this range is at $156.02, which is $1.61 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 01 Apr.

Presumably, on 04/01/2024, the price of shares will be in the range of $151.59 - $154.88. A $3.29 range width can provide 2.17% volatility. The weighted average price of this range is at $154.08, which is $1.95 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 02 Apr.

Presumably, on 04/02/2024, the price of shares will be in the range of $152.40 - $155.44. A $3.04 range width can provide 1.99% volatility. The weighted average price of this range is at $153.80, which is $0.28 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 03 Apr.

Presumably, on 04/03/2024, the price of shares will be in the range of $150.96 - $154.63. A $3.67 range width can provide 2.43% volatility. The weighted average price of this range is at $153.48, which is $0.32 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 05 Apr.

Presumably, on 04/05/2024, the price of shares will be in the range of $149.46 - $154.59. A $5.13 range width can provide 3.43% volatility. The weighted average price of this range is at $151.71, which is $0.55 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 06 Apr.

Presumably, on 04/06/2024, the price of shares will be in the range of $151.98 - $154.77. A $2.79 range width can provide 1.84% volatility. The weighted average price of this range is at $153.21, which is $1.50 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 07 Apr.

Presumably, on 04/07/2024, the price of shares will be in the range of $152.88 - $156.81. A $3.93 range width can provide 2.57% volatility. The weighted average price of this range is at $154.29, which is $1.08 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 08 Apr.

Presumably, on 04/08/2024, the price of shares will be in the range of $153.74 - $158.32. A $4.58 range width can provide 2.98% volatility. The weighted average price of this range is at $155.93, which is $1.64 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 09 Apr.

Presumably, on 04/09/2024, the price of shares will be in the range of $154.03 - $156.62. A $2.59 range width can provide 1.68% volatility. The weighted average price of this range is at $155.77, which is $0.16 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 10 Apr.

Presumably, on 04/10/2024, the price of shares will be in the range of $154.07 - $157.22. A $3.15 range width can provide 2.04% volatility. The weighted average price of this range is at $155.28, which is $0.49 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 11 Apr.

Presumably, on 04/11/2024, the price of shares will be in the range of $153.54 - $158.85. A $5.31 range width can provide 3.46% volatility. The weighted average price of this range is at $155.85, which is $0.57 higher than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 12 Apr.

Presumably, on 04/12/2024, the price of shares will be in the range of $153.10 - $154.82. A $1.72 range width can provide 1.12% volatility. The weighted average price of this range is at $153.90, which is $1.95 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 13 Apr.

Presumably, on 04/13/2024, the price of shares will be in the range of $152.07 - $156.46. A $4.39 range width can provide 2.89% volatility. The weighted average price of this range is at $153.46, which is $0.44 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 14 Apr.

Presumably, on 04/14/2024, the price of shares will be in the range of $151.47 - $155.82. A $4.35 range width can provide 2.87% volatility. The weighted average price of this range is at $153.42, which is $0.04 lower than the previous day's weighted average price.

Alnylam Pharmaceuticals Stock Forecast 15 Apr.

Presumably, on 04/15/2024, the price of shares will be in the range of $149.81 - $152.80. A $2.99 range width can provide 1.99% volatility. The weighted average price of this range is at $151.11, which is $2.31 lower than the previous day's weighted average price.

Read more

Alnylam Pharmaceuticals monthly stock forecast for 2024, 2025, 2026, 2027, 2028.

Table of forecasts for 2024.
Month Target Pes. Opt. Vol., %
Apr. 155.17 146.63 160.29 8.52
May. 168.14 161.67 182.57 11.45
Jun. 173.50 164.73 185.15 11.03
Jul. 171.79 160.07 186.34 14.10
Aug. 177.83 165.90 186.83 11.20
Sep. 169.03 160.48 175.17 8.39
Oct. 178.51 164.18 185.98 11.72
Nov. 187.55 179.09 192.70 7.07
Dec. 182.60 175.57 187.21 6.22

Diving into a more comprehensive insight, the monthly consensus forecast is an instrumental resource for investors eyeing Alnylam Pharmaceuticals's performance metrics. These projections are meticulously curated, leveraging insights from renowned global analysts and offering a panoramic view of the anticipated stock behaviour for the current year and beyond.

In the mid-term analysis, forecasting accuracy enhances, attributed to the diminished influence of transient market fluctuations. For this year, the zenith of Alnylam Pharmaceuticals share’s value is anticipated to touch $192.7, offering a robust metric for investment strategies, sans the extremes of varied agency forecasts.

On the contrary, the nadir projections settle at $146.63, delineating the lower threshold and offering a holistic perspective on the risk and return landscape.

Progressing further, we have extrapolated these analytical insights to generate consensus forecasts for subsequent years. The synthesized data, presented in intuitive tabular formats, offers investors, analysts, and enthusiasts a streamlined view into the future of Alnylam Pharmaceuticals stocks.

Anticipated Trends: Alnylam Pharmaceuticals (ALNY) Monthly Stock Trajectory for 2025

Table of forecasts for 2025.
Month Target Pes. Opt. Vol., %
Jan 202.08 190.07 219.42 13.37
Feb 187.18 183.07 191.92 4.61
Mar 183.27 169.36 189.93 10.83
Apr 180.65 167.74 184.63 9.15
May 189.99 173.27 195.22 11.24
Jun 204.41 191.82 217.90 11.97
Jul 209.81 194.11 225.50 13.92
Aug 228.73 209.11 235.78 11.31
Sep 240.06 225.53 248.77 9.34
Oct 234.51 224.45 254.12 11.67
Nov 247.41 231.35 252.85 8.50
Dec 258.29 235.56 274.49 14.18

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month Target Pes. Opt. Vol., %
Jan 244.66 231.47 257.84 10.23
Feb 245.19 229.82 256.52 10.41
Mar 262.46 250.33 284.40 11.98
Apr 277.76 258.20 295.48 12.62
May 299.45 288.91 324.81 11.05
Jun 331.40 302.60 359.84 15.91
Jul 339.06 312.20 367.03 14.94
Aug 338.31 328.64 354.31 7.25
Sep 349.85 324.83 372.94 12.90
Oct 316.37 292.70 330.64 11.47
Nov 316.37 302.79 341.77 11.40
Dec 325.07 315.77 342.59 7.83



Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month Target Pes. Opt. Vol., %
Jan 356.18 333.06 374.98 11.18
Feb 347.95 325.37 370.15 12.10
Mar 349.10 327.98 362.54 9.53
Apr 355.62 336.46 366.97 8.31
May 347.80 328.67 363.49 9.58
Jun 345.12 319.31 359.17 11.10
Jul 352.72 332.15 382.20 13.10
Aug 323.62 315.43 337.86 6.64
Sep 312.94 303.30 325.33 6.77
Oct 301.23 288.97 314.16 8.02
Nov 293.28 279.41 303.28 7.87
Dec 281.02 263.40 303.28 13.15

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2028

Table of forecasts for 2028.
Month Target Pes. Opt. Vol., %
Jan 305.44 282.60 326.95 13.56
Feb 321.91 314.47 339.61 7.40
Mar 318.72 304.70 333.79 8.72
Apr 321.87 296.03 347.37 14.78
May 332.85 316.01 351.52 10.10
Jun 315.64 296.89 327.79 9.43
Jul 281.62 267.37 288.12 7.20
Aug 271.39 248.70 278.26 10.62
Sep 246.32 228.70 265.01 13.70
Oct 226.81 217.58 239.28 9.07
Nov 225.56 211.67 240.45 11.97
Dec 215.14 201.18 222.95 9.77


Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


gayindia thefuckingtube.com hinde bf com
افلام اجنبى + 31 اون لاين hihitube.com شراميط نسوانجي
www hotwap com hardstreamsex.info sacred games xvideos
افلام سكس هولندى fransizporno.com نيك محارم جماعي
tamil in sex porno-ultimum.com wwxxxv
rakshita family photos hindixxxvideo.com www sexy dot com
kaokuma kanojo wowhentai.net akuochisukii sensei
فيديو نيك عربي arab-porn.net النيك فى الكس
سكس ليله 24pornload.com موقع سكس ساخن
sunny leone on xvideo pornoguru.info desi nude models
punjabi xxx videos onlyindianpornx.com www.x vedio.com
momson xvideos trashporn.mobi poren video com
حجاب بورن crazyporncomics.com ينيك امة
cumswapping anybunny.mobi pekham
sex nepali hamsterporn.mobi telugu bf vedios